PT - JOURNAL ARTICLE AU - C. Jaimes AU - S. Vajapeyam AU - D. Brown AU - P.-C. Kao AU - C. Ma AU - L. Greenspan AU - N. Gupta AU - L. Goumnerova AU - P. Bandopahayay AU - F. Dubois AU - N.F. Greenwald AU - T. Zack AU - O. Shapira AU - R. Beroukhim AU - K.L. Ligon AU - S. Chi AU - M.W. Kieran AU - K.D. Wright AU - T.Y. Poussaint TI - MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma AID - 10.3174/ajnr.A6546 DP - 2020 May 07 TA - American Journal of Neuroradiology 4099 - http://www.ajnr.org/content/early/2020/05/07/ajnr.A6546.short 4100 - http://www.ajnr.org/content/early/2020/05/07/ajnr.A6546.full AB - BACKGROUND AND PURPOSE: Recent advances in molecular techniques have characterized distinct subtypes of diffuse intrinsic pontine gliomas. Our aim was the identification of MR imaging correlates of these subtypes.MATERIALS AND METHODS: Initial MRIs from subjects with diffuse intrinsic pontine gliomas recruited for a prospective clinical trial before treatment were analyzed. Retrospective imaging analyses included FLAIR/T2 tumor volume, tumor volume enhancing, the presence of cyst and/or necrosis, median, mean, mode, skewness, kurtosis of ADC tumor volume based on FLAIR, and enhancement at baseline. Molecular subgroups based on EGFR and MGMT mutations were established. Histone mutations were also determined (H3F3A, HIST1H3B, HIST1H3C). Univariate Cox proportional hazards regression was used to test the association of imaging predictors with overall and progression-free survival. Wilcoxon rank sum, Kruskal-Wallis, and Fisher exact tests were used to compare imaging measures among groups.RESULTS: Fifty patients had biopsy and MR imaging. The median age at trial registration was 6 years (range, 3.3–17.5 years); 52% were female. On the basis of immunohistochemical results, 48 patients were assigned to 1 of 4 subgroups: 28 in MGMT–/epidermal growth factor receptor (EGFR)–, 14 in MGMT–/EGFR+, 3 in MGMT+/EGFR–, and 3 in MGMT+/EGFR+. Twenty-three patients had histone mutations in H3F3A, 8 in HIST1H3B, and 3 in HIST1H3C. Enhancing tumor volume was near-significantly different across molecular subgroups (P = .04), after accounting for the false discovery rate. Tumor volume enhancing, median, mode, skewness, and kurtosis ADC T2-FLAIR/T2 were significantly different (P ≤ .048) between patients with H3F3A and HIST1H3B/C mutations.CONCLUSIONS: MR imaging features including enhancement and ADC histogram parameters are correlated with molecular subgroups and mutations in children with diffuse intrinsic pontine gliomas.DIPGdiffuse intrinsic pontine gliomaEGFRepidermal growth factor receptorFDRfalse discovery ratePFSprogression-free survivalPGpostgadoliniumOSoverall survival